Stay updated on OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Sign up to get notified when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the page footer and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T08:10:35.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The Record History now shows a new revision entry: v3.3.2 has been added, replacing the previous v3.3.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:29:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The record history shows an addition of Revision: v3.3.1 and a deletion of Revision: v3.2.0. These updates are administrative and do not affect study data or displayed information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T10:59:33.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the page was removed. It previously informed users about potential delays and operating status.
    Difference
    0.7%
    Check dated 2025-11-17T06:07:54.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The history shows multiple versions with updates to recruitment status, study status, and study design. The version list now extends up to 2021-06-07.
    Difference
    0.1%
    Check dated 2025-11-03T00:45:41.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Summary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.
    Difference
    12%
    Check dated 2025-10-05T06:57:18.000Z thumbnail image

Stay in the know with updates to OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.